RCS-8
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 2-(2-methoxyphenyl)-1-[1-(2-cyclohexylethyl)indol-3-yl]ethanone | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 1345970-42-4  |
| ATC code | ? |
| ChemSpider | 24751863  |
| Chemical data | |
| Formula | C25H29NO2 |
| Mol. mass | 375.503 |
| SMILES | eMolecules & PubChem |
|
|
 (what is this?) (verify) |
RCS-8, or 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole, is a synthetic cannabinoid also known as SR-18 or BTM-8 that has been found as an ingredient of "herbal" synthetic cannabis blends. It can be described as an analogue of JWH-250 with the 1-pentyl group replaced by 1-(2-cyclohexylethyl), and can be expected to be less potent than JWH-250 (cf. JWH-007 and its cyclohexylethyl analogue).[1] Despite not having been reported in the scientific or patent literature as yet, reputed recreational use of RCS-8 in the United States has led to it being specifically listed in a proposed 2011 amendment to the Controlled Substances Act, aiming to add a number of synthetic drugs into Schedule I.[2]
[edit] See also
[edit] References
- ^ Huffmann JW, Dong D. Design, Synthesis and Pharmacology of Cannabimimetic Indoles. Bioorganic and Medicinal Chemistry Letters. 1994;4(4):563-566.
- ^ Synthetic Drug Control Act of 2011
 |
This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |
